GeneproDX has reached an agreement with Belgium’s Biocartis for the distribution of ThyroidPrint, a test that avoids unnecessary diagnostic surgeries and the permanent use of thyroid hormone supplements.
FDI news | Policies & Tools | Business data analysis | Investment location trends
GeneproDX has reached an agreement with Belgium’s Biocartis for the distribution of ThyroidPrint, a test that avoids unnecessary diagnostic surgeries and the permanent use of thyroid hormone supplements.
Topics: Innovation- Start-Up- Entrepreneurship- Science in Chile
Read MoreReceive in your e-mail publications and news about how to guide your investment project in Chile
100% Privacy. No Spam.